The Europe Cardiac Assist Devices Market is Segmented by Product (Intra-aortic Balloon Pump, Total Artificial Heart, and Ventricular Assist Device), and Geography (Germany, UK, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.

What is covered in the report about the “Italy Cardiac Assist Devices Market"? Read More

GlobalData’s “Italy Cardiac Assist Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Italy Cardiac Assist Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Intra-Aortic Balloon Pumps, Mechanical Circulatory Support Devices and Short-Term Circulatory Support Devices. Read More

Snapshot img

Heart Transplantation Therapeutics Market Size 2025-2029

The heart transplantation therapeutics market size is forecast to increase by USD 129.7 million, at a CAGR of 3% between 2024 and 2029.

The market is experiencing significant growth due to the increasing prevalence of ventricular assist devices and cardiovascular diseases, as well as heart failures. The need for organ preservation techniques during transplantation procedures is also driving market expansion. Moreover, the advancement of precision medicine and regenerative medicine is expected to revolutionize the heart transplantation landscape. However, the use of immunosuppressants for preventing organ rejection poses challenges due to their adverse effects, including increased risk of infections and cancer. The market is further influenced by international collaborations for heart transplantation research and development. Blood compatibility issues and ethical concerns are other factors shaping the market dynamics.

What will be the Size of the Heart Transplantation Therapeutics Market During the Forecast Period?

Request Free Sample

The market is specifically focused on heart transplantation therapeutics, is experiencing significant growth due to the increasing prevalence of cardiovascular disease and the ageing population. According to recent statistics, cardiovascular disease is the leading cause of mortality worldwide, with an estimated 17.9 million heart surgeries performed annually. The geriatric population, in particular, is a key driver of this market, as they are more susceptible to heart-related conditions. Heart transplantation remains a viable option for end-stage cardiac patients, with both orthotopic and heterotopic transplantation techniques being utilized. Heart transplant devices, such as heart-lung machines and implantable cardioverter-defibrillators, are essential components of these procedures.
Post-transplant care involves the use of immunosuppressants, anti-infectives, and analgesics to manage complications and ensure graft survival. Organ preservation techniques and advances in immunosuppressive therapies have improved transplant outcomes, leading to a growing number of successful procedures. Additionally, regenerative medicine approaches, including arrhythmia treatment and aneurysm repair, are emerging as potential alternatives to transplantation. The market for heart transplant therapeutics includes sales through hospitals, cardiac centers, hospital pharmacies, retail pharmacies, and online pharmacies.

How is this Heart Transplantation Therapeutics Industry segmented and which is the largest segment?

The heart transplantation therapeutics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Drug Class

  Immunosuppressants
  Anti-infectives
  Analgesics
  Others


Distribution Channel

  Hospital pharmacies
  Retail pharmacies
  Online pharmacies


Type

  Left ventricular assist device (LVAD)
  Heart transplantation
  Implantable cardiac defibrillator (ICD)
  Extracorporeal membrane oxygenation (ECMO)


Indication

  Ischemic heart disease (IHD)
  Dilated cardiomyopathy (DCM)
  Valvular heart disease (VHD)
  Hypertrophic cardiomyopathy (HCM)


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Drug Class Insights

The immunosuppressants segment is estimated to witness significant growth during the forecast period.

Immunosuppressants play a crucial role in organ transplantation procedures, particularly for non-identical donor-recipient matches. These drugs, including immunosuppressive medications and environmental toxins, prevent the recipient's immune system from rejecting the transplanted organ. Upon transplantation, the new organ is perceived as a foreign agent by the body's defense system, triggering an immune response aimed at damaging or destroying it. Immunosuppressants mitigate this response, enabling the new organ to integrate successfully. The geriatric population, afflicted by cardiovascular diseases such as heart failure, arrhythmias, aneurysms, and cardiomyopathy, often undergo heart transplantation procedures.

Hospitals, cardiac centers, and transplant institutes employ immunosuppressants, immunosuppressive therapies, regenerative medicine approaches, and organ preservation techniques to improve graft survival and enhance the quality of life for transplant recipients. Immunosuppressive drug regimens, antimicrobials, analgesics, and hospital and retail pharmacies are essential components of post-transplant care. Infectious complications, graft vasculopathy, and immunological challenges are ongoing concerns

Snapshot img

Structural Heart Disease Treatment Devices Market Size 2024-2028

The structural heart disease treatment devices market size is forecast to increase by USD 7.57 billion, at a CAGR of 10% between 2023 and 2028.

The market is witnessing significant growth, driven by the increasing prevalence of structural heart diseases. This trend is attributed to the aging population, rising obesity rates, and sedentary lifestyles leading to an increased incidence of heart conditions. Moreover, the strong clinical pipeline for heart valve devices is fueling market expansion, as these innovations offer less invasive and more effective treatment options. Treatment options include surgical procedures and the use of medical devices, such as heart valves and muscle support systems. The market for these devices is experiencing growth due to the increasing prevalence of structural heart diseases and the strong clinical pipeline for innovative heart valve devices. However, high costs associated with these procedures remain a significant challenge for both patients and healthcare systems. As a result, there is a growing emphasis on developing cost-effective solutions and reimbursement strategies to make these treatments more accessible.
Companies seeking to capitalize on market opportunities must focus on innovation, cost reduction, and strategic partnerships to navigate the competitive landscape and cater to the evolving needs of patients and healthcare providers.

What will be the Size of the Structural Heart Disease Treatment Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in technology and a growing emphasis on improving patient outcomes. Healthcare providers are increasingly leveraging data analytics to gain insights into patient conditions and optimize treatment plans. Atrial fibrillation (AFib), a common heart rhythm disorder, is a major focus area, with interventional cardiologists utilizing precision medicine and electrophysiology (EP) studies to deliver personalized care. Cardiac catheterization and minimally invasive procedures, such as cardiac ablation catheters and implantable cardioverter-defibrillators (ICDs), are gaining popularity due to their ability to enhance quality of life and reduce the need for open heart surgery. Regulatory approvals for innovative devices, such as bioabsorbable stents and AI-assisted diagnosis tools, are fueling market growth.

Patient satisfaction and survival rates are key performance indicators, with healthcare reimbursement and insurance coverage playing crucial roles in market dynamics. Digital health solutions, such as telemonitoring and remote patient monitoring, are transforming heart failure management and enabling earlier intervention. Medical device manufacturers are investing in R&D to develop new solutions for congenital heart defects, valvular heart disease, and other complex cardiac conditions. Machine learning (ML) and AI are being integrated into cardiac devices and diagnostic tools to improve accuracy and efficiency. Cardiac surgeons and medical imaging centers are collaborating to optimize care pathways and ensure timely intervention for patients.

The market is also witnessing the emergence of new players and collaborations, driven by the potential for significant growth in this evolving landscape. The cardiac devices market is expected to continue its dynamic trajectory, with ongoing advancements in technology, regulatory approvals, and clinical trials shaping the future of structural heart disease treatment. Cardiac biomarkers and genetic testing are also emerging as important tools in the quest for personalized care and improved patient outcomes.

How is this Structural Heart Disease Treatment Devices Industry segmented?

The structural heart disease treatment devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. MethodReplacement proceduresRepair proceduresEnd-UserHospitalsAmbulatory Surgical Centers (ASCs)Cardiac Catheterization LabsSpecialty ClinicsDisease IndicationAortic StenosisMitral RegurgitationTricuspid RegurgitationAtrial Septal Defect (ASD)Patent Foramen Ovale (PFO)Left Atrial Appendage ClosureCongenital Heart DefectsGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKMiddle East and AfricaEgyptKSAOmanUAEAPACChinaIndiaJapanSouth AmericaArgentinaBrazilRest of World (ROW)

By Method Insights

The replacement procedures segment is estimated to witness significant growth during the forecast period.

The market is driven by the increasing prevalence of structural heart diseases, such as atrial fibrillation, valvular heart di

Snapshot img

Implantable Medical Devices Market Size 2025-2029

The implantable medical devices market size is forecast to increase by USD 35.9 billion at a CAGR of 5.9% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of chronic illnesses and advancements in technology, particularly the adoption of 3D printing for implantable devices. However, this market faces notable challenges that require strategic navigation for companies seeking to capitalize on its potential. Regulatory hurdles, including stringent approval processes and compliance requirements, impact adoption and increase costs for manufacturers. Furthermore, high surgery costs associated with implant procedures can limit accessibility for patients, despite the benefits of these advanced medical solutions. These devices, which include insulin pumps, cosmetic implants, orthopedic implants such as knee replacements and spinal implants, ventricular assist devices, neurostimulation devices, dental implants, and implantable MRI systems, are transforming healthcare services.
To succeed in this market, companies must focus on addressing these challenges through innovative strategies, such as streamlining regulatory approvals and collaborating with healthcare providers to offer affordable financing options for patients. By staying abreast of market trends and addressing these challenges effectively, companies can capitalize on the significant growth opportunities presented by the market.

What will be the Size of the Implantable Medical Devices Market during the forecast period?

Request Free Sample

The market is experiencing significant advancements, driven by the integration of technology and biocompatible materials to enhance patient care and improve surgical precision. Informed consent processes are being augmented through digital platforms, enabling more transparent communication between healthcare providers and patients. Biocompatible coatings and bioabsorbable materials are revolutionizing device development, making implants more personalized and aligned with outcomes-based reimbursement. Precision surgery is being advanced through image-guided procedures and augmented reality, while remote diagnostics and haptic feedback facilitate connected healthcare. Value-based care and regulatory affairs are shaping the industry, driving innovation in areas such as tissue engineering, stem cell therapy, and gene therapy. Additionally, the increasing prevalence of chronic diseases like diabetes and cardiovascular conditions necessitates the development of more advanced and cost-effective implantable medical devices for chronic disease management. The market is expected to witness significant growth in the coming years, particularly in areas such as extremities, cardiac pacemakers, and insulin pumps.
Device tracking and supply chain management are becoming essential components of the healthcare ecosystem, ensuring patient safety and efficient delivery of care. Wearable technology, mobile health apps, and smart implants are transforming patient portal access and remote patient management, enabling a more proactive and personalized approach to healthcare. Industry consolidation continues to shape the landscape, with companies focusing on technology adoption, clinical research, and additive manufacturing to stay competitive. Biometric monitoring and cognitive enhancement are also emerging trends, as healthcare moves towards a more holistic and patient-centric approach. The future of implantable medical devices lies in the intersection of technology, biomaterials science, and healthcare policy, as we strive to deliver safer, more effective, and more accessible healthcare solutions.

How is this Implantable Medical Devices Industry segmented?

The implantable medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Orthopedic implants
  Cardiovascular implants
  Ophthalmic implants
  Dental implants
  Others


End-user

  Hospitals
  Clinics
  Others


Material

  Metallic
  Ceramic
  Natural
  Polymeric


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Type Insights

The orthopedic implants segment is estimated to witness significant growth during the forecast period. Implantable devices, including medical implants and orthopedic implants, are transforming healthcare through advances in digital health, precision medicine, and biocompatible materials. Orthopedic implants, such as joint replacements, are essential for treating various conditions, including knee injuries, hip fractures, spinal injuries, joint

Snapshot img { margin: 10px !important; } Cardiovascular Information System (CVIS) Market Size 2025-2029

The cardiovascular information system (CVIS) market size is forecast to increase by USD 971.0 million, at a CAGR of 11.6% between 2024 and 2029.

The global cardiovascular information system (CVIS) market is expanding, driven by the rising incidence of cardiac diseases, which necessitates advanced healthcare information systems for managing complex patient data. The increasing adoption of remote patient monitoring (RPM) is a significant trend, integrating ambulatory cardiac monitoring devices and other heart rate monitoring devices to enable continuous oversight. This shift enhances the capabilities of medical decision support systems market platforms by providing real-time data for proactive interventions. Effective management of cardiovascular diagnostic data within these clinical information systems is crucial for improving patient outcomes and streamlining care delivery across the cardiology service line, with a strong focus on patient data security.While technological advancements support market growth, significant challenges persist. Data security concerns related to CVIS are a primary hurdle, as these systems store highly sensitive patient health information. Healthcare organizations must implement robust data encryption protocols and secure user authentication methods to protect against cybersecurity threats and ensure regulatory compliance. This focus on security is essential for maintaining patient trust and the integrity of the healthcare IT ecosystem. The development of secure, interoperable cardiovascular ultrasound imaging systems and other cardiac ai monitoring and diagnostics tools is central to addressing these challenges and enabling the full potential of integrated cardiac care management.

What will be the Size of the Cardiovascular Information System (CVIS) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market is undergoing a significant transformation, driven by the need for enhanced clinical data integration and greater interoperability with EHR platforms. This evolution is enabling more cohesive patient care coordination by breaking down data silos between departments. The focus is on creating a unified patient medical history that is accessible across the care continuum. Developments in the healthcare information systems market are increasingly centered on platforms that support seamless diagnostic imaging workflows and provide comprehensive clinical data management capabilities, fostering a more connected healthcare IT ecosystem.Advanced healthcare data analytics and AI-driven diagnostics are becoming central to market development, fundamentally changing how cardiovascular diagnostic data is interpreted and used. These technologies facilitate sophisticated patient outcome analysis and offer predictive insights, turning information systems into active tools for evidence-based medicine support. The integration of AI in cardiology is improving the accuracy of structured cardiology reporting and automating aspects of clinical workflow automation. This shift is redefining the value proposition of the cardiac ai monitoring and diagnostics sector, moving beyond data storage to intelligent clinical guidance.

How is this Cardiovascular Information System (CVIS) Industry segmented?

The cardiovascular information system (CVIS) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments. TypeCVISC-PACSDeploymentWeb-basedOnsiteComponentSoftwareServicesGeographyNorth AmericaUSCanadaMexicoEuropeGermanyUKFranceItalyThe NetherlandsSpainAsiaRest of World (ROW)

By Type Insights

The cvis segment is estimated to witness significant growth during the forecast period.A Cardiovascular Information System (CVIS) functions as a comprehensive software solution that integrates patient medical history, diagnostic reports, and clinical data onto a unified digital platform. Its primary role is to optimize cardiology workflow optimization solutions and enhance collaboration among medical professionals. By centralizing cardiovascular diagnostic data, the system empowers healthcare providers with tools for effective clinical decision support in cardiology, thereby improving the accuracy and timeliness of patient care and treatment planning across the service line.This platform streamlines administrative and clinical processes, from initial diagnosis to long-term monitoring, while ensuring healthcare interoperability standards for CVIS are met through seamless integration with existing EHR systems. This connectivity minimizes data duplication and

Snapshot img

Orthopedic Plates And Screws Market Size 2025-2029

The orthopedic plates and screws market size is forecast to increase by USD 34.45 billion at a CAGR of 20.7% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of orthopedic conditions worldwide. According to the World Health Organization, musculoskeletal conditions account for an estimated 14% of the global burden of disease. This trend is particularly pronounced in emerging markets and untapped regions, where the burden of orthopedic conditions is increasing due to aging populations, urbanization, and lifestyle changes. However, the market faces challenges that may hinder its growth potential. Regulatory hurdles impact adoption, as stringent regulations and lengthy approval processes can delay market entry for new orthopedic implants. Furthermore, the high costs associated with these implants can limit accessibility, particularly in low-income countries and uninsured populations. These devices, which include insulin pumps, cosmetic implants, orthopedic implants such as knee replacements and spinal implants, ventricular assist devices, neurostimulation devices, dental implants, and implantable MRI systems, are transforming healthcare services.
Supply chain inconsistencies can also pose challenges, as the demand for orthopedic implants can be unpredictable, making it difficult for manufacturers to maintain a consistent supply. Companies seeking to capitalize on market opportunities and navigate challenges effectively must focus on developing cost-effective solutions, navigating regulatory landscapes, and building robust supply chains.

What will be the Size of the Orthopedic Plates And Screws Market during the forecast period?

Request Free Sample

The market encompasses a range of products, including joint replacement devices, trauma devices, spinal devices, and external fixation systems. Advanced technologies, such as finite element analysis and computer-aided engineering, are increasingly utilized in the design and development of these devices for improved biomechanical testing and surgical planning. Pre-operative planning using image-guided surgery and surgical navigation systems enhances accuracy and reduces healthcare costs. Orthopedic implants market growth is driven by the rising prevalence of musculoskeletal disorders, increasing demand for minimally invasive procedures, and the aging population. Patient education and payor landscape dynamics also influence market trends. Additionally, the increasing prevalence of chronic diseases like diabetes and cardiovascular conditions necessitates the development of more advanced and cost-effective implantable medical devices for chronic disease management. The market is expected to witness significant growth in the coming years, particularly in areas such as extremities, cardiac pacemakers, and insulin pumps.
Anti-bacterial coatings, corrosion resistance, and biocompatible coatings are essential features for implants, ensuring economic outcomes, clinical outcomes, functional outcomes, and patient satisfaction. The surgical implants market continues to evolve with advancements in biomechanical testing, bone grafting, and bone morphogenetic protein technology. Surgical simulation and quality of life assessments are crucial for assessing the impact of these devices on patients.

How is this Orthopedic Plates And Screws Industry segmented?

The orthopedic plates and screws industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals
  Ambulatory surgery centers


Type

  Plates
  Screws


Material

  Titanium
  Stainless steel
  Bioabsorbable
  PEEK polymer


Application

  Fracture Fixation
  Spinal Fusion
  CMF Surgeries
  Joint Replacement


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period. Orthopedic plates and screws are essential components in the healthcare industry, particularly in hospitals, where they play a crucial role in the treatment of various orthopedic conditions. The demand for these implants is driven by the rising prevalence of orthopedic diseases, including osteoarthritis, fractures, and sports injuries, which necessitate surgical interventions. The elderly population is another significant factor fueling the demand for orthopedic plates and screws, given their increased susceptibility to orthopedic conditions. Advancements in material science have led to the development of biocompatible material